|Articles|October 1, 2015
- BioPharm International-10-01-2015
- Volume 28
- Issue 10
BioPharm International, October 2015 Issue (PDF)
Click the title above to open the BioPharm International October 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
A Review of Glycan Analysis Requirementsabout 10 years ago
Evolving to Meet Industry Changesabout 10 years ago
Small-Molecule API CMOs Are Thrivingabout 10 years ago
Small-Scale and At-Scale Model Development and Optimizationabout 10 years ago
Market Access in ChinaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
